STRO - Sutro Biopharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

STRO is currently covered by 5 analysts with an average price target of $43.2. This is a potential upside of $-12.21 (156.23%) from yesterday's end of day stock price of $16.86.

Sutro Biopharma's activity chart (see below) currently has 78 price targets and 81 ratings on display. The stock rating distribution of STRO is 50% BUY and 50% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 73.07% with an average time for these price targets to be met of 556.44 days.

Highest price target for STRO is $60, Lowest price target is $23, average price target is $43.2.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 13-Aug-2026.

Currently out of the existing stock ratings of STRO, 4 are a BUY (50%), 4 are a HOLD (50%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-Aug-2026

$60

$43.14 (255.87%)

$60

1 months 1 days ago
(13-Aug-2026)

8/11 (72.73%)

$38.69 (181.56%)

913

Buy Since 13-Jan-2020

$50

$19.48 (63.83%)

3 months 3 days ago
(11-Jun-2026)

7/8 (87.5%)

$23.52 (88.82%)

599

Buy Since 09-Nov-2023

$55

$24.48 (80.21%)

$51

5 months 20 days ago
(25-Mar-2026)

2/4 (50%)

$31.5 (134.04%)

398

Hold Since 22-Dec-2025

$28

$-2.52 (-8.26%)

5 months 21 days ago
(24-Mar-2026)

3/3 (100%)

$4.43 (18.80%)

305

Hold Since 15-Aug-2025

$23

$-7.52 (-24.64%)

7 months 25 days ago
(20-Jan-2026)

12/12 (100%)

$8.08 (54.16%)

647

Show more analysts

Please expand the browser size to see the chart

What is STRO (Sutro Biopharma) average time for price targets to be met?

On average it took 556 days for the stock forecasts to be reached, with an average price target met ratio of 73.07%.

Which analyst most recently updated their price target on STRO (Sutro Biopharma)?

David Nierengarten

Which analyst has the most public recommendations on STRO (Sutro Biopharma)?

David Nierengarten works at WEDBUSH and has 4 price targets and 6 ratings on STRO

Which analyst is the currently most bullish on STRO (Sutro Biopharma)?

David Nierengarten with the highest potential upside of $43.14

Which analyst is the currently most reserved on STRO (Sutro Biopharma)?

Andrew Fein with the lowest potential downside of -$28.52

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?